TruBridge, Inc.
19.49-0.03 (-0.15%)
Oct 29, 4:00:01 PM EDT · NasdaqGS · TBRG · USD
Key Stats
Market Cap
292.58MP/E (TTM)
-Basic EPS (TTM)
-0.76Dividend Yield
0%Recent Filings
8-K
Q2 revenue steady, bookings rise
TruBridge reported Q2 2025 revenue of $85.7 million, edging up from $85.6 million a year ago, with bookings jumping to $25.6 million from $23.3 million. GAAP net income swung to $2.6 million from a $4.4 million loss, while Adjusted EBITDA ticked to $13.7 million. Client attrition trimmed full-year revenue guidance to $345-350 million, yet efficiencies boosted Adjusted EBITDA outlook to $62-67 million. Profitability rebounds, but larger deals slow revenue ramp.
10-Q
Q2 FY2025 results
TruBridge posted steady revenue growth in Q2 FY2025 ended June 30, 2025, with total revenues up 0.2% y/y to $85.7M, driven by a 1% rise in Patient Care while Financial Health held flat; y/y, six-month revenues climbed 2% to $172.9M. Operating income swung to $3.6M from a $2.1M loss, thanks to lower costs of revenues (down 5% y/y) and reduced amortization, yielding diluted EPS of $0.17 versus a $0.29 loss; net income beat operating by $0.1M, mainly from a tax benefit. Cash from operations hit $14.5M for the half, funding $1.8M in share repurchases amid $12.3M cash and $47.6M revolver availability, while total debt eased to $166.1M. The AHT sale in January 2024 added $21.4M cash then. Regulatory shifts like the One Big Beautiful Bill Act pose reimbursement risks for hospital clients.
8-K
Auditor change amid control weaknesses
TruBridge dismissed Grant Thornton as its auditor on June 25, 2025, effective immediately, after adverse opinions on internal controls for 2023 and 2024 due to material weaknesses in revenue processes and customer contract handling. The Audit Committee swiftly engaged KPMG as the new firm for the 2025 fiscal year, with no prior consultations or disagreements noted. No audit opinions were modified. This switch aims to address ongoing control issues.
10-Q
Q1 FY2025 results
TruBridge swung to operating income of $8.2M in Q1 FY2025 ended March 31, 2025, up from a $0.6M loss a year earlier, as revenues climbed 4% y/y to $87.2M on stronger Financial Health bookings and Patient Care installations, while costs of revenue dropped 5% y/y to 45% of sales thanks to offshore efficiencies. Gross margins expanded amid recurring revenue holding steady at 94% of total, with net income at $0.5M or $0.03 per diluted share on 14.4M shares, versus a $1.9M loss last year; the tax hit stemmed from a valuation allowance on deferred assets. Cash from operations hit $5.8M, funding $4.0M in software investments and $1.9M in share repurchases, leaving $10.1M in cash against $169M debt (7.3% rate, matures 2027) and $47M revolver availability under covenants met. The AHT sale last year boosted prior liquidity, but competition from bigger players with deeper pockets remains a persistent drag.
8-K
Board declassification approved
TruBridge stockholders approved declassifying the board at the May 8, 2025 annual meeting, effective for the 2026 election, and boosted the 2019 Incentive Plan's share pool by 1,850,000 shares to fuel talent retention. All directors won re-election handily, while advisory votes backed executive pay and auditor ratification. This governance shift enhances accountability, yet dilutes shares slightly.
IPO
Website
Employees
Sector
Industry
BTSG
BrightSpring Health Services, I
34.05+0.05
CCLD
CareCloud, Inc.
3.02-0.02
CMHSF
COMPREHENSIVE HEALTHCARE SYS IN
0.39+0.00
CTEV
Claritev Corporation
68.60-2.58
DH
Definitive Healthcare Corp.
2.77-0.17
GEHC
GE HealthCare Technologies Inc.
77.38-2.02
HCAT
Health Catalyst, Inc
3.34-0.04
PHLT
Performant Healthcare, Inc.
7.75+0.00
PHR
Phreesia, Inc.
23.22-0.19
PRVA
Privia Health Group, Inc.
25.60-0.33